The handheld ultrasound scanners market size is projected to reach US$ 1,404.397 million by 2031 from US$ 354.60 million in 2023. The market is expected to register a CAGR of 18.8% during 2023-2031.
Expanded application range of protein expression systems, including applications in the field of precision medicine, owing to the integration of artificial intelligence (AI) and automation technologies in protein expression workflows to enhance the efficiency, accuracy, and scalability of the overall process is likely to remain a key trend in the market.
Market Drivers of the Handheld Ultrasound Scanners Market
Increased Adoption of Handheld Point-Of-Care Ultrasound (POCUS) Devices
Point of care ultrasound (POCUS) is a flexible diagnostic tool that enables physicians to incorporate ultrasound imaging directly into patient evaluation and intervention. This instant access to medical imaging can speed up the process of diagnosis and treatment, which is especially helpful in emergencies. Therefore, POCUS has the potential to significantly improve patient outcomes in addition to increasing the efficacy of medical treatment. As POCUS makes better use of time and resources, it also has the potential to reduce healthcare expenditures. The use of point-of-care ultrasound (POCUS) devices is growing quickly among medical professionals, owing to their portability, the speed with which findings can be obtained to inform clinical judgment, and the fact that patients are not exposed to radiation. Many physicians now have better access to ultrasound owing to the recent proliferation of handheld ultrasound technologies. Physicians in emergency medicine, critical care, cardiology, and other specialties are increasingly utilizing POCUS for real-time diagnostic imaging, allowing for faster decision-making and improved patient outcomes. This shift toward decentralized ultrasound has led to a significant increase in demand for handheld scanners.
Growth of Telemedicine and Remote Monitoring to Create Market Opportunities
The growth of telemedicine and remote patient monitoring is expected to create significant opportunities for the handheld ultrasound scanners market. These portable devices are valuable tools for expanding access to diagnostic imaging and enhancing patient care in remote and underserved areas. The ability to conduct ultrasound examinations remotely through telemedicine allows healthcare providers to reach patients who may not have access to traditional ultrasound services. This is beneficial in rural areas, where access to specialists and advanced medical technology can be limited. Handheld ultrasound scanners and high-speed internet connectivity enable real-time image transmission and remote consultations, facilitating timely diagnoses and treatment plans. For instance, elderly patients can receive point-of-care ultrasound scanners from rural general practitioners (GPs) in the comfort of their homes rather than going to a hospital owing to the tele-mentored handheld ultrasound system (tele-HHUS) technology.
Moreover, the rise of remote patient monitoring programs is creating a demand for portable diagnostic tools that patients can use at home or in other nonclinical settings. Handheld ultrasound scanners are ideal for monitoring chronic conditions such as heart disease, lung disease, and vascular disorders, enabling patients to track their health status and receive timely interventions if necessary. The combination of telemedicine and remote patient monitoring drives the adoption of handheld ultrasound scanners, as they provide a convenient, cost-effective, and accessible solution for expanding healthcare services beyond traditional settings. The adoption of handheld ultrasound scanners is likely to continue as technology advances and healthcare providers increasingly embrace telehealth and remote patient monitoring programs.
Handheld Ultrasound Scanners Market: Segmental Overview
Key segments that contributed to the derivation of the handheld ultrasound scanners market analysis are product type, application, and end user.
- Based on product type, the handheld ultrasound scanners market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.
- By application, the market is segmented into genomic research, gene therapy, bioproduction, cancer research, and drug development. The genomic research segment accounted for the largest share of the market in 2023.
- Based on end user, the handheld ultrasound scanners market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment dominated the market in 2023.
Handheld Ultrasound Scanners Market: Geographical Overview
The geographic scope of the handheld ultrasound scanners market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. North America dominated the market in 2023. The North America Handheld Ultrasound Scanners market has been analyzed on the basis of the US, Canada, and Mexico. The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and respiratory diseases, the development of innovative products, and the presence of key market players in the region has increased the demand of handheld ultrasound scanners in North American countries. The US held the largest share of the market in North America in 2023. According to a Cancer Statistics report published by the American Cancer Society Journal in January 2024, ~2 million new cases of cancer and 611,720 deaths from cancer are projected to occur in the US in 2024. The rising prevalence of cancer increases the demand for ultrasound imaging devices, including handheld ultrasound scanners. A handheld ultrasound scanner is a compact and portable ultrasound device designed for use in small spaces, at a patient's bedside, or in the field in real time to aid in the early diagnosis and treatment of cancer.